Amgen 2007 Annual Report Download - page 76

Download and view the complete annual report

Please find page 76 of the 2007 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Item 5(c). UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS AND ISSUER
PURCHASES OF EQUITY SECURITIES
During the three months ended December 31, 2007, we had two outstanding stock repurchase programs. The
manner of purchases, the amount we spend and the number of shares repurchased will vary based on a variety of
factors, including the stock price and blackout periods in which we are restricted from repurchasing shares and
may include private block purchases as well as market transactions. Repurchases under our stock repurchase
program reflect, in part, our confidence in the long-term value of Amgen common stock. Additionally, we be-
lieve that it is an effective way of returning cash to our stockholders. A summary of our repurchase activity for
the three months ended December 31, 2007 is as follows:
Total
Number of
Shares
Purchased
Average
Price Paid
per Share
Total Number
of Shares
Purchased as
Part of
Publicly
Announced
Programs
Maximum $
Value that May
Yet Be Purchased
Under the
Programs(1)
October 1 — October 31 ........................ $ — $6,539,425,047
November 1 — November 30 .................... 625 56.84 — 6,539,425,047
December 1 — December 31 .................... 1,842,272 54.39 1,838,431 6,439,425,117
1,842,897(2) 54.39 1,838,431(2)
(1) In December 2006, the Board of Directors authorized us to repurchase up to $5.0 billion of common stock.
As of December 31, 2007, $1.4 billion was available for stock repurchases under our stock repurchase pro-
gram authorized by the Board of Directors in December 2006. Additionally, in July 2007, the Board of
Directors authorized us to repurchase up to an additional $5.0 billion of common stock.
(2) The difference between total number of shares purchased and the total number of shares purchased as part of
publicly announced programs is due to shares of common stock withheld by us for the payment of taxes
upon vesting of certain employees’ restricted stock.
64